☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Neutralizing
BeiGene Signs an Exclusive License Agreement with Singlomics for Neutralizing COVID-19 Antibodies
August 27, 2020
AstraZeneca Plans to Advance the Combination of Neutralizing Antibody for COVID-19 into Clinical in Next Two Months
June 10, 2020
AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2 Virus
April 9, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.